Single arterial access closure of post-infarction ventricular septal defect: A case series.
amplatzer occluder device
percutaneous closure
trans-arterial access
ventricular septal defect
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
23
09
2022
received:
18
06
2022
accepted:
24
11
2022
pubmed:
9
12
2022
medline:
21
1
2023
entrez:
8
12
2022
Statut:
ppublish
Résumé
Post-infarction ventricular septal defect (PIVSD) carries a very poor prognosis. Surgical repair offers reasonable outcomes in patients who survive the initial healing period. Percutaneous device implantation remains a potentially effective earlier alternative. From March 2018 to May 2022, 11 trans-arterial PIVSD closures were attempted in 9 patients from two centers (aged 67.2 ± 11.1 years; 77.8% male). Two patients had a second procedure. Myocardial infarction was anterior in four patients (44.5%) and inferior in five cases (55.5%). Devices were successfully implanted in all patients. There were no major immediate procedural complications. Immediate shunt grade postprocedure was significant (11.1%), minimal (77.8%), or none (11.1%). Median length of stay after the procedure was 14.8 days. Five patients (55%) survived to discharge and were followed up for a median of 605 days, during which time no additional patients died. Single arterial access for percutaneous closure of PIVSD is a good option for these extremely high-risk patients, in the era of effective large-bore arterial access closure. Mortality remains high, but patients who survive to discharge do well in the longer term.
Sections du résumé
BACKGROUND
Post-infarction ventricular septal defect (PIVSD) carries a very poor prognosis. Surgical repair offers reasonable outcomes in patients who survive the initial healing period. Percutaneous device implantation remains a potentially effective earlier alternative.
METHODS AND RESULTS
From March 2018 to May 2022, 11 trans-arterial PIVSD closures were attempted in 9 patients from two centers (aged 67.2 ± 11.1 years; 77.8% male). Two patients had a second procedure. Myocardial infarction was anterior in four patients (44.5%) and inferior in five cases (55.5%). Devices were successfully implanted in all patients. There were no major immediate procedural complications. Immediate shunt grade postprocedure was significant (11.1%), minimal (77.8%), or none (11.1%). Median length of stay after the procedure was 14.8 days. Five patients (55%) survived to discharge and were followed up for a median of 605 days, during which time no additional patients died.
CONCLUSION
Single arterial access for percutaneous closure of PIVSD is a good option for these extremely high-risk patients, in the era of effective large-bore arterial access closure. Mortality remains high, but patients who survive to discharge do well in the longer term.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
209-216Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (global utilization of streptokinase and TPA for occluded coronary arteries) trial investigators. Circulation. 2000;101(1):27-32. doi:10.1161/01.cir.101.1.27
Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol. 2010;106(8):1095-1100. doi:10.1016/j.amjcard.2010.06.013
Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35(31):2060-2068. doi:10.1093/eurheartj/ehu248
Lopez-Sendon J, Gurfinkel EP, Lopez de Sa E, et al. Factors related to heart rupture in acute coronary syndromes in the global registry of acute coronary events. Eur Heart J. 2010;31(12):1449-1456. doi:10.1093/eurheartj/ehq061a
Deville C, Fontan F, Chevalier J, Madonna F, Ebner A, Besse P. Surgery of post-infarction ventricular septal defect: risk factors for hospital death and long-term results. Eur J Cardiothorac Surg. 1991;5(4):167-175. doi:10.1016/1010-7940(91)90026-g
Papadopoulos N, Moritz A, Dzemali O, et al. Long-term results after surgical repair of postinfarction ventricular septal rupture by infarct exclusion technique. Ann Thorac Surg. 2009;87(5):1421-1425. doi:10.1016/j.athoracsur.2009.02.011
Coskun KO, Coskun ST, Popov AF, et al. Experiences with surgical treatment of ventricle septal defect as a post infarction complication. J Cardiothorac Surg. 2009;4(1):1-5. doi:10.1186/1749-8090-4-3
Barker T, Ramnarine IR, Woo EB, et al. Repair of post-infarct ventricular septal defect with or without coronary artery bypass grafting in the northwest of England: a 5-year multi-institutional experience. Eur J Cardiothorac Surg. 2003;24(6):940-946. doi:10.1016/s1010-7940(03)00465-2
O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;127(4):529-555. doi:10.1161/CIR.0b013e3182742cf6
Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177. doi:10.1093/eurheartj/ehx393
Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H. Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention. 2016;12(1):94-102. doi:10.4244/EIJV12I1A17
Calvert PA, Cockburn J, Wynne D, et al. Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experience. Circulation. 2014;129(23):2395-2402. doi:10.1161/CIRCULATIONAHA.113.005839
Holzer R, Balzer D, Amin Z, et al. Transcatheter closure of postinfarction ventricular septal defects using the new amplatzer muscular VSD occluder: results of a US registry. Catheter Cardiovasc Interv. 2004;61(2):196-201. doi:10.1002/ccd.10784
Spaziano M, Thériault-Lauzier P, Meti N, et al. Optimal fluoroscopic viewing angles of left-sided heart structures in patients with aortic stenosis and mitral regurgitation based on multislice computed tomography. J Cardiovasc Comput Tomogr. 2016;10(2):162-172. doi:10.1016/j.jcct.2015.12.007
Hamilton MCK, Rodrigues JCL, Martin RP, Manghat NE, Turner MS. The in vivo morphology of post-infarct ventricular septal defect and the implications for closure. JACC Cardiovasc Interv. 2017;10(12):1233-1243. doi:10.1016/j.jcin.2017.03.042
Wahl A, Meier B. Patent foramen ovale and ventricular septal defect closure. Heart. 2008;95(1):70-82. doi:10.1136/hrt.2007.121038
Hildick-Smith D, Briceno N, Alsanjari O, et al. Amplatzer post-infarction ventricular septal defect closure via retrograde transarterial access: easier and better. Struct Heart. 2021;5(3):263-268. doi:10.1080/24748706.2021.1894371
Hildick-Smith DJR, Khan ZI, Shapiro LM, Petch MC. Occasional-operator percutaneous brachial coronary angiography: first, do no arm. Catheter Cardiovasc Interv. 2002;57(2):161-165. doi:10.1002/ccd.10329
Sarathy K, Patel KP, Jones DM, et al. Large bore vascular access closure device strategies. Struct Heart. 2021;5(2):186-191. doi:10.1080/24748706.2021.1872818